HER-2 amplification is highly homogenous in gastric cancer—reply

Hum Pathol. 2010 Feb;41(2):305-306, Andreas H. Marx, Ronald Simon, Guido Sauter

We very much appreciate the comments by Bilous et al further expanding the important discussion on HER2 amplification and overexpression in gastric cancer. The data provided by Bilous et al are to a large extent consistant with our findings. For example, their unpublished tissue multi array (TMA) study of 170 gastric cancer cases showed strikingly similar results: In 19.4% (n = 33) of the cases gene amplification strongly correlated with protein overexpression (as compared to 16% in our series of...

NOT A MEMBER?

Registration is FREE

  • Up-to-date oncology news
  • Journal article summaries
  • Commentaries and interviews
  • Drug and interactions database
  • Chemotherapy regimens
  • Daily e-newsletters

 

Editors' Choice

Long-Term Posttransplant Bortezomib Boosts Outcome in Myeloma With del(17p13)

Sign up for our newsletters

Too busy to follow cancer's top stories? Sign-up for 1 or more of our free newsletters -- delivered weekly to your inbox.

Cancer Type

  • Bladder
  • Bone
  • Breast
  • Breast (ER-Positive)
  • CNS/Brain
  • Colon and Rectum
  • Endocrine System
  • Esophagus
  • GYN (Non-Ovary)
  • GYN (Ovary)
  • Head and Neck
  • Hodgkin's Lymphoma
  • Kidney (Renal Cell)
  • Leukemia
  • Liver and Bile Duct
  • Lung
  • Multiple Myeloma
  • Myelodysplastic Syndrome
  • Myeloproliferative Diseases
  • Non-Hodgkin's Lymphoma
  • Pancreas
  • Pediatric Cancers
  • Prostate
  • Rare Cancers
  • Skin
  • Soft-Tissue Sarcoma
  • Stomach
  • Testicle
  • Forgot your password?
    Not a member? Free registration